Steve Lisi

CEO and Chairman of the Board

Steven Lisi has served on our Board since January 2017 and on the Board of Beyond Air Ltd., our wholly-owned subsidiary, since June 2016. Mr. Lisi was previously Senior Vice President of Business and Corporate Development at Avadel Pharmaceuticals (AVDL) where he was instrumental in restructuring the company, raising $121 million and transforming it from $100 million enterprise value to $1 billion in three years. Prior to his position at Avadel, Mr. Lisi spent 18 years investing in the global healthcare industry at SAC Capital, Millennium Management and Deerfield Management amongst others. He received his master’s degree in International Business from Pepperdine University.

Amir Avniel

President and Chief Operating Officer

Amir Avniel is the COO and co-founder of Beyond Air. He has over 20 years of experience leading biotechnology companies. Prior to Beyond Air, he co-founded Rosetta Green, which was eventually acquired by Monsanto. Prior to Rosetta Green, he served as the president and the Chief Executive Officer of Rosetta Genomics, a NASDAQ company. He studied computer science at the Academic College of Tel Aviv – Jaffa Israel and earned a bachelor’s degree in Social Sciences and Humanities from Open University in Israel. Prior to his academic studies, he served as an officer in the Israel Defense Force, where he was awarded four commendations for excellence.

Duncan Fatkin

Chief Commercial Officer

Duncan Fatkin joined Beyond Air as its Chief Commercial Officer in January 2019. Mr. Fatkin has a successful track record in the global medical device and biopharmaceutical industries, building out commercial capabilities, leading marketing and sales teams, and cultivating strong thought leader relationships across multiple specialties. His 30 years of experience includes, most recently, roles with Becton Dickinson (Worldwide Vice President, Injection, Diabetes Care), Zimmer Biomet (Vice President and General Manager, Office Based Technologies), Smith & Nephew/Bioventus (Vice President, Global Marketing & Reimbursement) and DePuy/Johnson & Johnson (Worldwide Vice President, iOrthopaedics). Mr. Fatkin has spent more than 10 years of his career in both Europe and the Asia Pacific region, with the last 9+ years in the United States. He received his bachelor of arts degree in Materials Science from Oxford University and his Diploma in Marketing from Thames Valley University.

Douglas Beck

Chief Financial Officer

Douglas Beck, CPA joined Beyond Air as its Chief Financial Officer in November 2018. Mr. Beck has been a Chief Financial Officer for five public companies, three of which were biotechnology companies. Mr. Beck has assisted companies’ raising equity and debt in excess of $100 million. He spent over four years at Lev Pharmaceutical, Inc. until the completion of a $618 million sale of the company. Mr. Beck serves on the New York State Society of CPAs Chief Financial Officer and SEC committee.

Frederick Montgomery, PhD

Vice President of Medical Systems

Fred Montgomery has spent the last 25 years developing and patenting NO delivery system technology leading to the commercialization of nitric oxide therapy. He led the development of the INOvent delivery system for Datex-Ohmeda, which in 1999 was the first FDA 510(k) cleared nitric oxide delivery system that led to the commercial marketing of INO Therapy in the year 2000. He established the Medical Device Group at INO Therapeutics which developed the INOmax DS and DSIR products, the leading NO delivery systems in the United States to this day. Mr. Montgomery left Ikaria (formerly INO Therapeutics) in 2011 and co-founded NitricGen Inc. He received his Doctor of Philosophy degree from the University of Salford, England and his Master’s of Business Administration from the University of Bradford, England.

Michael Gaul

Senior Vice President, Operations

Michael Gaul joined Beyond Air as its Senior VP, Operations in May 2020. Mr. Gaul has a proven track record in multiple Industries that include: Medical Devices and Reagents, Semiconductor Automation Capital Equipment, Public Safety Communication Systems and Complex Industrial Controls and Instrumentation. He has led teams in operations, sales & marketing, supply chain, distribution, quality, regulatory, human resources and finance. He has had P&L experience with multi-plant responsibility in both the US and Asia, including roles with Sparton Corporation (Group VP, Manufacturing & Design Services Business Unit; Group VP, Medical Business Unit), SynCardia Systems (COO; VP Operations), Ventana Medical (VP & General Manager, Operations), Robotic Vision Systems, INC (General Manager, Vanguard Division; VP Operations, Systemation Division). He currently serves on the Board of Directors of BioOhio to support and promote Ohio’s bioscience industry. Mr. Gaul has a BS, Business Administration from Delaware Valley University and an MBA from Florida Institute of Technology.

Rebecca Van Doren

Head of Sales

Rebecca Van Doren brings over 20 years of healthcare leadership and sales experience to Beyond Air, dedicating the majority of her career to envisioning and invigorating winning commercial strategies for nitric oxide, both in the US and Australia with Ikaria and Mallinckrodt Pharmaceuticals. She has crafted and led commercialization programs for medical device and pharmaceutical products in global companies, including, most recently, Fresenius Medical Care. As an accomplished commercial leader, Ms. Van Doren unites business with science into comprehensive, global programs that support highly successful product launches of complex drug/devices within hospitals and health systems. As an industry-recognized sales leader, she recruits, mentors, and develops top talent to develop a world class sales team to maximize opportunity while assuring customer-centricity and focusing on exceptional service. As Head of Sales at Beyond Air, Ms. Van Doren will lead all sales operations for the US.

Kori-Ann Taylor

Head of Marketing

Kori-Ann Taylor joins Beyond Air as an experienced marketing leader within the healthcare industry. She has a strong track record of success in developing winning strategies, building results-driven teams, and driving integrated marketing campaigns in rapidly changing competitive landscapes across various device and pharmaceutical brands. Ms. Taylor joins Beyond Air from aptihealth, where she served as the Chief Marketing Officer, responsible for brand building, developing, and leading all marketing initiatives and launches across health plans and hospital systems. Before her time at aptihealth, Ms. Taylor spent over a decade as an award-winning account lead at highly respected marketing agencies, including Fingerpaint Marketing and Palio, leading U.S. and global campaign development and launches for healthcare brands. While at Fingerpaint, she was the marketing account lead for the industry nitric oxide leader, under both Ikaria and Mallinckrodt Pharmaceuticals. She successfully led the development and implementation of comprehensive marketing strategies and integrated campaigns supporting year-over-year double-digit sales growth. As Head of Marketing at Beyond Air, Ms. Taylor will drive the development and execution of comprehensive marketing strategies across all products and launches. She also will oversee corporate and product brand building for Beyond Air's extensive pipeline, positioning Beyond Air for tremendous growth.